CTI(SZ:300012) Xin Lang Cai Jing·2025-09-24 05:57Core Viewpoint - 华测检测 has shown a mixed performance in stock price and financial metrics, with a slight increase in stock price recently but a decline over the past few trading days. The company continues to grow its revenue and profit year-on-year, indicating a stable business model in the testing services industry [1][2]. Financial Performance - As of June 30, 2025, 华测检测 achieved a revenue of 2.96 billion yuan, representing a year-on-year growth of 6.05% [2]. - The net profit attributable to shareholders for the same period was 467 million yuan, reflecting a year-on-year increase of 7.03% [2]. - Cumulatively, the company has distributed 1.077 billion yuan in dividends since its A-share listing, with 436 million yuan distributed over the last three years [3]. Stock Market Activity - On September 24, 2023, 华测检测's stock price increased by 2.05%, reaching 12.92 yuan per share, with a trading volume of 224 million yuan and a turnover rate of 1.23% [1]. - The total market capitalization of the company is approximately 21.742 billion yuan [1]. - The stock has seen a year-to-date increase of 4.78%, but has declined by 1.07% over the last five trading days and 5.07% over the last twenty days [1]. Shareholder Structure - As of June 30, 2025, the number of shareholders for 华测检测 increased to 81,100, a rise of 4.53% from the previous period [2]. - The largest shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, which is an increase of 7.8679 million shares from the previous period [3]. - The top ten circulating shareholders include various ETFs, with notable changes in holdings among them [3]. Business Segmentation - 华测检测's main business segments include life sciences (43.02%), industrial testing (20.31%), consumer product testing (17.64%), trade assurance (14.39%), and medical services (4.64%) [1].